Jasper Therapeutics Inc.

NASDAQ: JSPR · Real-Time Price · USD
3.07
0.04 (1.32%)
At close: Aug 15, 2025, 3:59 PM
3.05
-0.65%
After-hours: Aug 15, 2025, 06:15 PM EDT

Jasper Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-71.27M -64.47M -37.69M -30.64M
Depreciation & Amortization
1.37M 1.11M 975K 377K
Stock-Based Compensation
6.62M 5.21M 4.09M 1.05M
Other Working Capital
295K 2.06M 2.17M -1.32M
Other Non-Cash Items
502K 976K -12.59M -9.09M
Deferred Income Tax
n/a n/a n/a 3M
Change in Working Capital
173K 5.1M -649K 1.62M
Operating Cash Flow
-62.6M -52.07M -45.86M -33.68M
Capital Expenditures
-552K -267K -576K -2.43M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
20K n/a n/a n/a
Investing Cash Flow
-532K -267K -576K -2.43M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
689K -508K n/a 90.22M
Financial Cash Flow
47.88M 100.97M 55K 100.97M
Net Cash Flow
-15.25M 48.64M -46.38M 64.86M
Free Cash Flow
-63.15M -52.33M -46.43M -36.11M